QUOTED. John Milad.
Since closing its $245m funding raise, Quanta Dialysis Technologies has been scaling up its commercial infrastructure and bolstering its US presence. CEO John Milad told Medtech Insight what that means for the company.
“We have to have multidisciplinary teams in place to support our product – we don’t just supply a piece of equipment, we support it. Building out our supply chain has also been critical. It’s no good getting sales orders if you can’t provide enough product.” – John Milad, CEO, Quanta Dialysis Technologies
Click here for a free trial of Medtech Insight